Xiaosong Wang

11PUBLICATIONS
29CO-AUTHORS
Molecular targetsBiological adaptationTumour immunologyGene expression (incl. microarray and other genome-wide approaches)Genomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 29, 2026
DEA hypothesis: disinhibition, enhancing recognition, and alerting the host are the three pillars of effective cancer immunotherapy.

|Jun 29, 2026
Guarding epithelial integrity: origins of adaptive immunity and cancer immunosurveillance over time and space.

|May 08, 2026
Tumors hijack immune-privileging regulons via distinct cell types to confer T cell desertion and immunotherapy resistance across various cancers.

|Apr 02, 2026
Bright side of the dark genome: antigens for next-gen cancer vaccines.

Xiao-Song Wang, Bernard A Fox

|Aug 29, 2024
ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes.

Megan E Yates, Hunter Waltermire, Kanako Mori

|Aug 13, 2024
Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion.

Yue Wang, Mengying Hu, Olivera J Finn

Pageof 2

Frequent Collaborators

3 joint publications

Sanghoon Lee

2 joint publications

Han Zhang

2 joint publications

Leif W Ellisen

2 joint publications

Lee Zou